European Union - English - EMA (European Medicines Agency)

intervet international b.v. - inactivated leptospira strains: l. interrogans serogroup canicola serovar portland-vere (strain ca-12-000); l. interrogans serogroup icterohaemorrhagiae serovar copenhageni (strain ic-02-001); l. interrogans serogroup australis serovar bratislava (strain as-05-073); l. kirschneri serogroup grippotyphosa serovar dadas (strain gr-01-005) - immunologicals for canidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - dogs - for active immunisation of dogs against:l. interrogans serogroup canicola serovar canicola to reduce infection and urinary excretion;l. interrogans serogroup icterohaemorrhagiae serovar copenhageni to reduce infection and urinary excretion;l. interrogans serogroup australis serovar bratislava to reduce infection;l. kirschneri serogroup grippotyphosa serovar bananal/lianguang to reduce infection and urinary excretion.

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - rabies virus (inactivated) - rabies virus (inactivated) 0 vaccine - vaccine

United Kingdom - English - VMD (Veterinary Medicines Directorate)

intervet international bv - bordetella bronchiseptica, canine parainfluenza virus - nasal drops, lyophilisate and solvent for suspension - live bacterial and viral vaccine - dogs

European Union - English - EMA (European Medicines Agency)

intervet international bv - live bordetella bronchiseptica bacteria strain b-c2 - immunologicals for felidae, - cats - for active immunisation of cats, of 1 month of age or older to reduce clinical signs of bordetella bronchiseptica associated upper respiratory tract disease.onset of immunity: onset of immunity was established in 8 week old cats as early as 72 hours after vaccination.duration of immunity: the duration of immunity is up to 1 year.no data on the influence of maternal antibodies on the effect of vaccination with nobivac bb for cats are available. from literature it is considered that this type of intranasal vaccine is able to induce an immune response without interference from maternally derived antibodies.

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - bordetella bronchiseptica; canine parainfluenza - nasal drops, lyophilisate and solvent for suspension - . - live bacterial and viral vaccine - dogs - immunological - live vaccine

United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - bordetella bronchiseptica, canine parainfluenza virus - nasal drops, lyophilisate and solvent for suspension - live bacterial and viral vaccine - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - bordetella bronchiseptica, canine parainfluenza virus - nasal drops, lyophilisate and solvent for suspension - live bacterial and viral vaccine - dogs

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - live myxoma vectored rhd virus strain 009, live myxoma vectored rhd virus strain mk1899 - immunologicals for leporidae - rabbits - for active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and rabbit haemorrhagic disease (rhd) caused by classical rhd virus (rhdv1) and rhd type 2 virus (rhdv2).

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunologicals for canidae - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

European Union - English - EMA (European Medicines Agency)

intervet international bv - live myxoma-vectored rabbit-haemorrhagic-disease virus strain 009 - immunologicals - rabbits - for active immunisation of rabbits from five weeks of age onwards to reduce mortality and clinical signs of myxomatosis and to prevent mortality due to rabbit haemorrhagic disease.onset of immunity: 3 weeks.duration of immunity: 1 year.